Recognising and overcoming unconscious bias is important to all health-care providers. ASHM's #RemovingBarriers web… https://t.co/J6xFumWJJJ
ASHM Report Back
Clinical posts from members and guests of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) from various international medical and scientific conferences on HIV, AIDS, viral hepatitis, and sexual health.
Cobistat
The new "booster" drug, COBISTAT, is part of the "QUAD" single pill (see QUAD post) and a number of studies are in planning and in progress looking at the use of this agent. It may allow new regimens such as a once daily combination pill with a protease inhibitor for the first time.
Tagged in:
CROI2012
Trackback URL for this blog entry.
